AstraZeneca has announced a $15bn investment in China by 2030 to expand manufacturing and R&D.

GC Therapeutics has appointed Kate Haviland as Board Chair.

Genentech has announced positive topline results from a phase 2 trial of CT-388, its investigational therapy to treat obesity ...

The state of California in the US is suing the nation’s largest insulin manufacturers and pharmacy benefit managers (PBMs) for allegedly using their market power to overcharge patients for the ...

Tamer Mohamed, founder and CEO at Aspect Biosystems added: “Our partnership with Novo Nordisk combines more than a century of ...

Emotive has appointed Terri Cooper as Chair of the Board and Mark Swindell as Non-Executive Director.

Sanofi and Regeneron’s Dupixent (dupilumab) has received positive final draft guidance from the National Institute for Health ...

GlaxoSmithKline (GSK) has announced that Arexvy, its respiratory syncytial virus (RSV) vaccine, has received expanded ...

Emotive has appointed Terri Cooper as Chair of the Board and Mark Swindell as Non-Executive Director.

In response to ISPOR’s recently published 2026-2027 HEOR Trends, David Miller, CEO, Genesis Research Group, suggests that ...

Ipsen has appointed Pierrick Lefranc as Executive Vice President (EVP) Technical Operations, as well as a member of its Executive Leadership Team (ELT).

Sanofi has announced that its amlitelimab has shown positive results in the treatment of patients 12 years and older with ...